CASI Pharmaceuticals CASIF Cash Flow Statement (2021-2025)

OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT
Reported Financials

CASI Pharmaceuticals Quarterly Cash Flow Statement

Periods 17 quarters
Latest Dec 2025

CASI Pharmaceuticals cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 17 quarters of results from Dec 2021 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income -8.15M-11.03M-8.15M-12.92M-5.63M-12.25M-4.64M-3.74M-9.43M-7.28M-8.44M-14.10M-11.20M-13.39M-10.91M-83.61M
Gains from Investment SecuritiesGains Investment -1.56M-1.15M0.70M-6.88M-0.14M-0.94M0.01M0.49M1.86M1.25M-1.25M0.11M-0.02M
Additional items
Ending Cash Balance 38.70M47.11M17.08M13.47M5.63M

CASI Pharmaceuticals Cash Flow Statement API

Pull CASI Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CASIF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY